Nicholas Investment Partners’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.29M | Buy |
146,941
+37,202
| +34% | +$1.34M | 0.47% | 85 |
|
|
2025
Q1 | $4.33M | Buy |
109,739
+25,592
| +30% | +$1.01M | 0.45% | 94 |
|
|
2024
Q4 | $2.53M | Sell |
84,147
-25,559
| -23% | -$769K | 0.22% | 143 |
|
|
2024
Q3 | $2.57M | Buy |
+109,706
| New | +$2.57M | 0.24% | 149 |
|
|
2022
Q2 | – | Sell |
-129,050
| Closed | -$1.23M | – | 205 |
|
|
2022
Q1 | $1.23M | Sell |
129,050
-156,759
| -55% | -$1.49M | 0.09% | 163 |
|
|
2021
Q4 | $5.43M | Sell |
285,809
-200,029
| -41% | -$3.8M | 0.34% | 105 |
|
|
2021
Q3 | $16.2M | Sell |
485,838
-175,126
| -26% | -$5.83M | 1.18% | 16 |
|
|
2021
Q2 | $25.6M | Buy |
660,964
+35,177
| +6% | +$1.36M | 1.61% | 4 |
|
|
2021
Q1 | $30.2M | Sell |
625,787
-2,385
| -0.4% | -$115K | 2.1% | 1 |
|
|
2020
Q4 | $32.7M | Buy |
628,172
+398,720
| +174% | +$20.7M | 2.52% | 1 |
|
|
2020
Q3 | $6.14M | Buy |
+229,452
| New | +$6.14M | 0.66% | 53 |
|